Previous 10 | Next 10 |
Calithera Biosciences (NASDAQ: CALA ) prices its public offering and sells 5M common shares at $6.25/share, for expected gross proceeds of $31.25M. More news on: Calithera Biosciences, Inc., Healthcare stocks news, , Stocks on the move, Read more ...
SOUTH SAN FRANCISCO, Calif., April 16, 2020 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today announce...
Gainers: RCUS +49.2% . LTRPB +13.1% . CGEN +15.9% . AM +15.3% . BBBY +12.1% . More news on: Arcus Biosciences, Inc., Liberty TripAdvisor Holdings, Inc., Compugen Ltd., Stocks on the move, , Read more ...
SOUTH SAN FRANCISCO, April 14, 2020 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small-molecule drugs for the treatment of cancer and other life-threatening diseases, shared an update on bu...
SCWorx (NASDAQ: WORX ) +171% on order for 2M COVID-19 blood tests. More news on: SCWorx Corp., Can-Fite BioPharma Ltd., Independence Contract Drilling, Inc., Stocks on the move, , Read more ...
Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 150 weeks of public selections as part of this ongoing live forward-testing. In...
Calithera Biosciences (NASDAQ: CALA ) initiated with Buy rating and $6 (34% upside) price target at Jefferies. More news on: Calithera Biosciences, Inc., bluebird bio, Inc., Charles River Laboratories International, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 148 weeks of public selections as part of this ongoing live forward-testing. In...
Calithera Biosciences, Inc. (CALA) Q4 2019 Earnings Conference Call March 11, 2020 5:00 PM ET Company Participants Jennifer McNealey - Vice President of Investor Relations and Strategy Susan Molineaux - Founder, President & Chief Executive Officer Keith Orford - Chief Medical...
Calithera Biosciences (NASDAQ: CALA ): Q4 GAAP EPS of -$0.39 misses by $0.02 . More news on: Calithera Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Calithera Biosciences Inc. Company Name:
CALA Stock Symbol:
OTCMKTS Market:
Calithera Biosciences Inc. Website:
Williams Industrial Services Group Inc. (WLMSQ) is expected to report $-0.15 for Q3 2023 Cellcom Israel Limited (CELJF) is expected to report for quarter end 2023-09-30 Central Japan Railway Co ADR (CJPRY) is expected to report for Q2 2024 CW Petroleum Corp (CWPE) is expected to repor...
Strategic Environmental & Energy Resources Inc (SENR) is expected to report for Q1 2024 Biocept Inc. (BIOCQ) is expected to report for Q1 2024 Kalera Public Limited Company (KALRQ) is expected to report for quarter end 2023-09-30 Lanvin Group Holdings Limited (LANV) is expected to...
Murata Manufacturing Co. Ltd. ADR (MRAAY) is expected to report $0.27 for Q2 2024 Quotient Limited (QTNTQ) is expected to report for quarter end 2023-09-30 Evaxion Biotech A/S (EVAX) is expected to report for Q3 2023 American Virtual Cloud Technologies Inc. (AVCTQ) is expected to repo...